West Pharmaceutical Services Inc (BSP:W2ST34)
R$ 55.16 0.16 (0.29%) Market Cap: 139.83 Bil Enterprise Value: 138.71 Bil PE Ratio: 48.32 PB Ratio: 8.58 GF Score: 89/100

Q2 2023 West Pharmaceutical Services Inc Earnings Call Transcript

Jul 27, 2023 / 01:00PM GMT
Release Date Price: R$48.85
Operator

Thank you for standing by, and welcome to the West Pharmaceutical Services Q2 2023 Earnings Conference Call. (Operator Instructions) Please be advised today's conference call is being recorded.

I would now like to turn the call over to Mr. Quintin Lai, Vice President of Investor Relations. Please go ahead.

Quintin J. Lai
West Pharmaceutical Services, Inc. - VP of Strategy & IR

Thank you, Valerie. Good morning, and welcome to West's Second Quarter 2023 Conference Call. We issued our financial results this morning and the release has been posted in the Investors section on the company's website located at westpharma.com.

This morning, Eric Green and Bernard Birkett will review our financial results, provide an update on our business and present an update on our financial outlook for the full year 2023. There's a slide presentation that accompanies today's call and a copy of that presentation is available on the Investors section of our website.

On Slide 4 is our safe harbor statement. Statements made by management on this call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot